These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3032089)

  • 1. Activity of (+)-cyclaradine (Sch 31172) against herpes simplex virus in vitro and in vivo.
    Schwartz J; Ostrander M; Butkiewicz NJ; Lieberman M; Lin C; Lim J; Miller GH
    Antimicrob Agents Chemother; 1987 Jan; 31(1):21-6. PubMed ID: 3032089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice.
    Shannon WM; Westbrook L; Arnett G; Daluge S; Lee H; Vince R
    Antimicrob Agents Chemother; 1983 Oct; 24(4):538-43. PubMed ID: 6651280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbocyclic arabinofuranosyladenine (cyclaradine): efficacy against genital herpes in guinea pigs.
    Vince R; Daluge S; Lee H; Shannon WM; Arnett G; Schafer TW; Nagabhushan TL; Reichert P; Tsai H
    Science; 1983 Sep; 221(4618):1405-6. PubMed ID: 6684328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.
    Sakuma S; Yamamoto M; Kumano Y; Mori R
    Arch Virol; 1988; 101(3-4):169-82. PubMed ID: 2845890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined acyclovir and vidarabine on infection with herpes simplex virus in vitro and in vivo.
    Park NH; Callahan JG; Pavan-Langston D
    J Infect Dis; 1984 May; 149(5):757-62. PubMed ID: 6327850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
    O'Brien WJ; Taylor JL
    Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides.
    Smee DF; Campbell NL; Matthews TR
    Antiviral Res; 1985 Oct; 5(5):259-67. PubMed ID: 2998275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus mutants resistant to arabinosyladenine in the presence of deoxycoformycin.
    Fleming HE; Coen DM
    Antimicrob Agents Chemother; 1984 Sep; 26(3):382-7. PubMed ID: 6095755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.
    Schinazi RF; Peters J; Williams CC; Chance D; Nahmias AJ
    Antimicrob Agents Chemother; 1982 Sep; 22(3):499-507. PubMed ID: 6182836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive mucocutaneous herpes simplex infection due to acyclovir-resistant virus in an immunocompromised patient: correlation of viral susceptibilities and plasma levels with response to therapy.
    Bean B; Fletcher C; Englund J; Lehrman SN; Ellis MN
    Diagn Microbiol Infect Dis; 1987 Jul; 7(3):199-204. PubMed ID: 2820649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H; McMillan A; Darby G
    J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
    Ayisi NK; Gupta SV; Babiuk LA
    Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro and in vivo antiherpes virus activities of the acyclic nucleosides, acyclovir (Zovirax) and 9-[(2-hydroxy-1-hydroxymethylethoxy)methyl]guanine (BWB759U).
    Collins P; Oliver NM
    Antiviral Res; 1985 Jun; 5(3):145-56. PubMed ID: 2992369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
    Field HJ; Lay E
    Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice.
    Crane LR; Milne DA; Sunstrum JC; Lerner AM
    Antimicrob Agents Chemother; 1984 Oct; 26(4):557-62. PubMed ID: 6083754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient.
    Christophers J; Sutton RN
    J Antimicrob Chemother; 1987 Sep; 20(3):389-98. PubMed ID: 2824424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of pyrophosphate analogues on cutaneous herpes simplex virus type 1 infection in guinea pigs.
    Wutzler P; Helbig B; Ulbricht A; Meerbach A; Pradel W
    Antiviral Res; 1988 Nov; 10(1-3):99-106. PubMed ID: 2852923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.